{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T09:49:30Z","timestamp":1648633770246},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T00:00:00Z","timestamp":1207180800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s00115-008-2436-z","type":"journal-article","created":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T17:11:24Z","timestamp":1207069884000},"page":"617-629","source":"Crossref","is-referenced-by-count":7,"title":["Behandlungs- und Versorgungsstrategien bei Alzheimer und verwandten Demenzen"],"prefix":"10.1007","volume":"79","author":[{"given":"H.","family":"F\u00f6rstl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,3]]},"reference":[{"key":"2436_CR1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000094973","volume":"22","author":"Ag\u00fcero-Torres","year":"2006","unstructured":"Ag\u00fcero-Torres H, Kivipelto M, von Strauss E (2006) Rethinking the dementia diagnosis in a population-based study: what is Alzheimer\u2019s disxease and what is vasclar dementia? Dement Geriat Cogn dis 22: 244\u2013249","journal-title":"Dement Geriat Cogn dis"},{"key":"2436_CR2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bmj.38740.439664.DE","volume":"332","author":"Ancelin","year":"2006","unstructured":"Ancelin ML, Artero S, Portet F et al. (2006) Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 332: 455\u2013459","journal-title":"BMJ"},{"key":"2436_CR3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/01.wnl.0000266625.31615.f6","volume":"69","author":"Auchus","year":"2007","unstructured":"Auchus AP, Brashear HR, Sallloway S et al. (2007) Galantamine treatment of vascular dementia. Neurology 69: 448\u2013458","journal-title":"Neurology"},{"key":"2436_CR4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00115-006-2248-y","volume":"78","author":"Bartels","year":"2007","unstructured":"Bartels C, Wallesch CW (2007) Diagnostik bei chronisch fortschreitenden Demenzen. CME-Weiterbildung. Der Nervenarzt 78: 597\u2013607","journal-title":"Der Nervenarzt"},{"key":"2436_CR5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1034\/j.1600-0579.2003.00210.x","volume":"51","author":"Brodaty","year":"2003","unstructured":"Brodaty H, Green A, Koschera A (2003) Meta-analysis of psychosocial interventions for caregivers of people with dementia. JAGS 51: 657\u2013664","journal-title":"JAGS"},{"key":"2436_CR6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000104872","volume":"24","author":"Calabrese","year":"2007","unstructured":"Calabrese P, Essner U, F\u00f6rstl H (2007) Memantine in clinical practice. Dement Geriatr Cogn Dis 24: 111\u2013117","journal-title":"Dement Geriatr Cogn Dis"},{"key":"2436_CR7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-2005-870962","volume":"74","author":"Diehl","year":"2006","unstructured":"Diehl J, Ernst J, Krapp S et al. (2006) Frontotemporale Demenz und delinquentes Verhalten. Fortschritte der Neurol Psychiat 74: 203\u2013210","journal-title":"Fortschritte der Neurol Psychiat"},{"key":"2436_CR8","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"Dubois","year":"2007","unstructured":"Dubois B, Feldman HH, Jacova C et al. (2007) Research criteria fort he diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA-criteria. Lancet Neurology 6: 734\u2013746","journal-title":"Lancet Neurology"},{"key":"2436_CR9","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1055\/s-2007-979399","volume":"132","author":"Egert","year":"2007","unstructured":"Egert S, Wagenpfeil S, F\u00f6rstl H (2007) Cholinesterase-Inhibitoren und Alzheimer Demenz: Metaanalyse zu Wirksamkeitsnachweis, Ursprung und Ergebnisverzerrung in publizierten Studien. DMW 132: 1207\u20131213","journal-title":"DMW"},{"key":"2436_CR10","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","volume":"351","author":"Emre","year":"2004","unstructured":"Emre M, Aarsland D, Alabanese A et al. (2004) Rivastigmine for dementia associated with Parkinson\u2019s disease. N Engl J Med 351: 2509\u20132518","journal-title":"N Engl J Med"},{"key":"2436_CR11","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","volume":"351","author":"Fahn","year":"2004","unstructured":"Fahn S, Oakes D, Shoulson I et al. (2004) Levodopa and the progression of Parkinson\u2019s disease. N Engl J Med 351: 2498\u20132508","journal-title":"N Engl J Med"},{"key":"2436_CR12","doi-asserted-by":"crossref","unstructured":"F\u00f6rstl H (2005) Frontalhirn Funktionen und Erkrankungen. Springer, Heidelberg","DOI":"10.1007\/b138170"},{"key":"2436_CR13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1055\/s-2008-1046730","volume":"133","author":"F\u00f6rstl","year":"2008","unstructured":"F\u00f6rstl H, Bickel H, Fr\u00f6lich L et al. (2008) MCI-plus: leichte kognitive St\u00f6rungen mit Vorzeichen rascher Verschlechterung. DMW 133: 431\u2013436","journal-title":"DMW"},{"key":"2436_CR14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1192\/bjp.163.3.364","volume":"163","author":"F\u00f6rstl","year":"1993","unstructured":"F\u00f6rstl H, Burns A, Levy R et al. (1993) Neuropathological correlates of behavioural disturbance in confirmed Alzheimer\u2019s disease. Brit J Psychiat 163: 364\u2013368","journal-title":"Brit J Psychiat"},{"key":"2436_CR15","first-page":"394","volume":"45","author":"F\u00f6rstl","year":"1995","unstructured":"F\u00f6rstl H, Hentschel F, Sattel H et al. (1995) Age-associated memory impairment and early Alzheimer disease only time will tell the difference. Arzneimittelforschung 45: 394\u2013397","journal-title":"Arzneimittelforschung"},{"key":"2436_CR16","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1161\/01.STR.0000170642.39876.f2","volume":"36","author":"Hart","year":"2005","unstructured":"Hart RG, Tonarelli SB, Pearce LA (2005) Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke 36: 1588\u20131593","journal-title":"Stroke"},{"key":"2436_CR17","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1176\/appi.ajp.2007.06101710","volume":"164","author":"Kales","year":"2007","unstructured":"Kales HC, Valenstein M, Kim HM et al. (2007) Mortality risk in patients treated with antipsychotics versus other psychiatric medications. Am J Psychiat 164: 1568\u20131576","journal-title":"Am J Psychiat"},{"key":"2436_CR18","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1212\/01.wnl.0000242727.81172.91","volume":"14","author":"Mittelman","year":"2006","unstructured":"Mittelman MS, Haley WE, Clay OJ et al. (2006) Imroving caregiver well-being delays nuring home placement of patients with Alzheimer disease. Neurology 14: 1592\u20131599","journal-title":"Neurology"},{"key":"2436_CR19","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","volume":"63","author":"Ownby","year":"2006","unstructured":"Ownby RL, Crocco E, Acevedo A et al. (2006) Depression and risk for Alzheimer disease. Arch Gen Psychiat 63: 530\u2013538","journal-title":"Arch Gen Psychiat"},{"key":"2436_CR20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF03327430","volume":"18","author":"Panza","year":"2006","unstructured":"Panza F, Solfrizzi V, Colacicci AM et al. (2006) Cerebrovascular disease in the elderly: lipoprotein metabolism and cognitive decline. Aging Clin Exp Res 18: 144\u2013148","journal-title":"Aging Clin Exp Res"},{"key":"2436_CR21","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/01.STR.0000217653.01615.93","volume":"37","author":"Peila","year":"2006","unstructured":"Peila R, White LR, Masaki K et al. (2006) Reducing the risk of dementia: efficacy of long-term treatment of hypertension. Stroke 37: 1165\u20131170","journal-title":"Stroke"},{"key":"2436_CR22","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/jnnp.2006.094714","volume":"77","author":"Perneczky","year":"2006","unstructured":"Perneczky R, Drzezga A, Diehl-Schmid J et al. (2006) Schooling mediates brain reserve in Alzheimer\u2019s disease. J Neurol Neurosurg Psychiat 77: 1060\u20131063","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"2436_CR23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1503\/cmaj.061250","volume":"176","author":"Schneeweiss","year":"2007","unstructured":"Schneeweiss S, Setoguchi S, Brookhart A et al. (2007) Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ 176: 627\u2013632","journal-title":"CMAJ"},{"key":"2436_CR24","doi-asserted-by":"crossref","unstructured":"Schwalen S, F\u00f6rstl H (2008) Sechs Fragen zur Alzheimer Demenz: Wissen und Einstellung in einer repr\u00e4sentativen Bev\u00f6lkerungsstichprobe. Neuropsychiatrie (im Druck)","DOI":"10.5414\/NEPBand22035"},{"key":"2436_CR25","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jama.293.5.596","volume":"293","author":"Sink","year":"2005","unstructured":"Sink KM, Holden K, Yaffe K (2005) Pharmacological treatment of neuropsychiatric symptoms of dementia. JAMA 293: 596\u2013608","journal-title":"JAMA"},{"key":"2436_CR26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","volume":"291","author":"Tariot","year":"2004","unstructured":"Tariot PN, Farlow MR, Grossberg GT et al. (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 291: 317\u2013324","journal-title":"JAMA"},{"key":"2436_CR27","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","volume":"163","author":"Tzourio","year":"2003","unstructured":"Tzourio C, Anderson C, Chapman N et al. (2003) Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Int Med 163: 1069\u20131075","journal-title":"Arch Int Med"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-008-2436-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-008-2436-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-008-2436-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T05:08:32Z","timestamp":1558588112000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-008-2436-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,3]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["2436"],"URL":"https:\/\/doi.org\/10.1007\/s00115-008-2436-z","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,3]]}}}